Tag:
festinavir
Latest Headlines
Latest Headlines
BMS, Oncolys ink HIV pact
Bristol-Myers Squibb ( $BMY ) and Japan's Oncolys BioPharma have signed a definitive agreement for festinavir, a next-generation, orally available nucleoside reverse transcriptase inhibitor in Phase II
